GSTM1-null and GSTA1-low activity genotypes are associated with enhanced oxidative damage in bladder cancer

References

• McGrath M, Michaud D, De Vivo I. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. BMC Cancer 2006;6:239–47.
   PubMed Web of Science ®Google Scholar
• Simic T, Savic-Radojevic A, Pljesa-Ercegovac M, Matic M, Mimic-Oka J. Glutathione S-transferases in kidney and urinary bladder tumors. Nat Rev Urol 2009;6:281–9.
   PubMed Web of Science ®Google Scholar
• Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51–88.
   PubMed Web of Science ®Google Scholar
• Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000;61:154–66.
   PubMed Web of Science ®Google Scholar
• Coles FB, Kadlubar FF. Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. In: , Sies H, Lester P, (eds.) Glutathione transferases and gamma-glutamyl transpeptidases, methods enzymology. London: Elsevier Academic Press; 2005. p. 9–42.
   Google Scholar
• Engel LS, Taioli E, Pfeiffer R, Garcia-Closas M, Marcus PM, Lan Q, et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 2002;156:95–109.
   PubMed Web of Science ®Google Scholar
• Garcia-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005;366:649–59.
   PubMed Web of Science ®Google Scholar
• Matic M, Pekmezovic T, Djukic T, Mimic-Oka J, Dragicevic D, Krivic B, et al. GSTA1, GSTM1, GSTP1 and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study. Urol Oncol, accepted for publication.
   Web of Science ®Google Scholar
• Palma S, Cornetta T, Padua L, Cozzi R, Appolloni M, Ievoli E, et al. Influence of glutathione S-transferase polymorphisms on genotoxic effects induced by tobacco smoke. Mutat Res 2007;633:1–12.
   PubMed Web of Science ®Google Scholar
• Simic T, Mimic-Oka J, Savic-Radojevic A, Opacic M, Pljesa M, Dragicevic D, et al. Glutathione S-transferase T1–1 activity upregulated in transitional cell carcinoma of urinary bladder. Urology 2005;65:1035–40.
   PubMed Web of Science ®Google Scholar
• Savic-Radojevic A, Mimic-Oka J, Pljesa-Ercegovac M, Opacic M, Dragicevic D, Kravic T, et al. Glutathione S-transferase-P1 expression correlates with increased antioxidant capacity in transitional cell carcinoma of the urinary bladder. Eur Urol 2007;52:470–7.
   PubMed Web of Science ®Google Scholar
• Badjatia N, Satyam A, Singh P, Seth A, Sharma A. Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma. Urol Oncol 2010;28:360–7.
   PubMed Web of Science ®Google Scholar
• Soini Y, Haapasaari KM, Vaarala MH, Turpeenniemi-Hujanen T, Kärjä V, Karihtala P. 8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma. Int J Clin Exp Pathol 2011;4:267–75.
   PubMed Web of Science ®Google Scholar
• Matsui A, Ikeda T, Enomoto K, Hosoda K, Nakashima H, Omae K, et al. Increased formation of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett 2000;151:87–95.
   PubMed Web of Science ®Google Scholar
• Shen J, Deininger P, Hunt JD, Zhao H. 8-Hydroxy-2′-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer. Cancer 2007;109:574–50.
   PubMed Web of Science ®Google Scholar
• Chiou CC, Chang PY, Chan EC, Wu TL, Tsao KC, Wu JT. Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers. Clin Chim Acta 2003;334:87–94.
   PubMed Web of Science ®Google Scholar
• Chung CJ, Huang CJ, Pu YS, Su CT, Huang YK, Chen YT, et al. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area. Toxicol Appl Pharmacol 2008;226:14–21.
   PubMed Web of Science ®Google Scholar
• Garcia-Clocas M, Kelsey KT, Hankinson SF, Spiegelman D, Springer K, Willett WC, et al. Glutathione S-transferase mu and theta polymorphisms and breast cancer susceptibility. J Natl Cancer Inst 1999;91:1960–4.
   PubMedGoogle Scholar
• Ping J, Wang H, Huang M, Liu ZS. Genetic analysis of glutathione S-transferase A1 polymorphism in the Chinese population and the influence of genotype on enzymatic properties. Toxicol Sci 2006;89:438–43.
   PubMed Web of Science ®Google Scholar
• Filiadis I, Hrouda D. Genetic factors in chemically-induced transitional cell bladder cancer. BJU Int 2000;86:794–801.
   PubMed Web of Science ®Google Scholar
• Valavanidis A, Vlachogianni T, Fiotakis K. Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int J Environ Res Public Health 2009;6:445–62.
   PubMed Web of Science ®Google Scholar
• Yu H, Xia Q, Yan J, Herreno-Saenz D, Wu YS, Tang IW, et al. Photoirradiation of polycyclic aromatic hydrocarbons with UVA light - a pathway leading to the generation of reactive oxygen species, lipid peroxidation, and DNA damage. Int J Environ Res Public Health 2006;3:348–54.
   PubMedGoogle Scholar
• Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem J 2007;401:1–11.
   PubMed Web of Science ®Google Scholar
• Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic Biol Med 2010;49:1603–16.
   PubMed Web of Science ®Google Scholar
• Malins DC, Haimanot R. Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res 1991;51:5430–2.
   PubMed Web of Science ®Google Scholar
• Mitropoulos D, Deliconstantinos G, Zervas A, Giannopoulos A, Kyriakou G, Dimopoulos C. Oxidative stress of red blood cells during Bacillus Calmette-Guerin intravesical instillations. In Vivo 2000;14:721–4.
   Google Scholar
• Matic M, Simic T, Dragicevic D, Mimic-Oka J, Pljesa-Ercegovac M, Savic-Radojevic A. Isoenzyme profile of glutathione transferases in transitional cell carcinoma of upper urinary tract. Transl Res 2010;155:256–62.
   PubMed Web of Science ®Google Scholar
• Pljesa-Ercegovac M, Savic-Radojevic A, Dragicevic D, Mimic-Oka J, Matic M, Sasic T, et al. Enhanced GSTP1 expression in transitional cell carcinoma of urinary bladder is associated with altered apoptotic pathways. Urol Oncol 2011;29:70–7.
   PubMed Web of Science ®Google Scholar
• De Martino M, Klatte T, Schatzl G, Remzi M, Waldert M, Haitel A, et al. Renal cell carcinoma Fuhrman grade and histological subtype correlate with complete polymorphic deletion of glutathione S-transferase M1 gene. J Urol 2010;183:878–83.
   PubMed Web of Science ®Google Scholar
• Nørskov MS, Frikke-Schmidt R, Bojesen SE, Nordestgaard BG, Loft S, Tybjærg-Hansen A. Copy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general population. Pharmacogenomics J 2011;11:292–9.
   PubMed Web of Science ®Google Scholar